2022
Fertility Preservation in Breast Cancer Patients
Marin L, Turan V, Oktay K. Fertility Preservation in Breast Cancer Patients. 2022, 185-198. DOI: 10.1007/978-3-030-47767-7_14.Peer-Reviewed Original ResearchFertility preservation issuesBreast cancerGonadotropin-releasing hormone agonistNovel chemotherapy regimensSafety of pregnancyFertility preservation techniquesBreast cancer survivorsBreast cancer patientsBreast cancer survivalPremature ovarian insufficiencyBreast cancer treatmentChemotherapy regimensOvarian suppressionPremenopausal womenOvarian reserveHormone agonistCancer survivorsCommon malignancyFertility preservationOvarian functionCancer patientsCancer survivalBRCA mutationsSexual dysfunctionFertility risks
2021
Preservation of fertility in cancer patients: BRCA mutations, ovarian tissue cryopreservation and transplantation, and pharmacological treatments in fertility preservation
Oktay K. Preservation of fertility in cancer patients: BRCA mutations, ovarian tissue cryopreservation and transplantation, and pharmacological treatments in fertility preservation. The Biomedical & Life Sciences Collection 2021, 2021: e1005610. DOI: 10.69645/qtwq1550.Peer-Reviewed Original Research
2020
Impact of breast cancer chemotherapy on ovarian damage and recovery.
Goldfarb S, Bedoschi G, Turan V, Crown A, Abdo N, Dickler M, Oktay K. Impact of breast cancer chemotherapy on ovarian damage and recovery. Journal Of Clinical Oncology 2020, 38: e24059-e24059. DOI: 10.1200/jco.2020.38.15_suppl.e24059.Peer-Reviewed Original ResearchAMH recoveryBreast cancerBaseline AMHOvarian reserveNon-metastatic breast cancerBaseline AMH levelsTime of diagnosisBreast cancer patientsBreast cancer chemotherapyImpact of chemoImportant predictorCancer ptsChemo groupGonadotoxic chemoChemotherapy regimenOvarian damageSerum AMHAMH levelsStudy entryTamoxifen treatmentFertility preservationLow AMHProspective studyCancer patientsFuture fertility
2019
Advances in fertility-preservation surgery: navigating new frontiers
Christianson M, Oktay K. Advances in fertility-preservation surgery: navigating new frontiers. Fertility And Sterility 2019, 112: 438-445. PMID: 31446903, DOI: 10.1016/j.fertnstert.2019.06.029.Peer-Reviewed Original ResearchConceptsFertility preservation surgeryFertility preservationSurgical optionsVital reproductive organFertility-preserving surgeryUterine fixationRadical trachelectomyGynecologic malignanciesFemale patientsFirst transplantationCancer patientsReproductive organsFuture fertilityReproductive surgeryMedical conditionsTransposition procedureSelect cancersSurgerySurgical creativityTissue 20PatientsMajor advancesOrgansTrachelectomyTransplantation
2018
Ovarian tissue cryopreservation and transplantation
Bedoschi G, Oktay K. Ovarian tissue cryopreservation and transplantation. 2018, 148-152. DOI: 10.1201/9781351141680-19.Peer-Reviewed Original ResearchOvarian tissue cryopreservationOvarian cortical piecesFertility preservationAdvanced treatment strategiesOvarian transplantationCortical piecesOvarian stimulationSurvival outcomesOvarian functionTreatment strategiesTissue cryopreservationAccelerated phaseEarly detectionHeterotopic ovarian transplantationFertility preservation proceduresLower abdominal wallFirst descriptionOvarian endocrineInitial ischemiaOvarian cryopreservationPharmacological supportTransplant proceduresFollicle lossCancer careCancer patients
2016
Embryo Cryopreservation in Breast Cancer Patients
Bedoschi G, Oktay K. Embryo Cryopreservation in Breast Cancer Patients. 2016, 39-52. DOI: 10.1007/978-4-431-55963-4_3.Peer-Reviewed Original ResearchBreast cancer patientsCancer patientsFertility preservationEmbryo cryopreservationAdjuvant systemic chemotherapyFertility preservation techniquesOvarian stimulation protocolsBreast cancer casesOvarian stimulationSystemic chemotherapyOvarian reserveIncident casesAromatase inhibitorsBreast cancerCancer casesStimulation protocolPatientsDonor semenCommon typeWomenFuture reproductive potentialCancerPreservation techniquesAttractive strategySpecial considerationCurrent State of Fertility Preservation in Cancer Patients—What is Established and What is Still Controversial?
Oktay K, Bedoschi G. Current State of Fertility Preservation in Cancer Patients—What is Established and What is Still Controversial? TouchREVIEWS In Oncology & Haematology 2016, 12: 33. DOI: 10.17925/ohr.2016.12.01.33.Peer-Reviewed Original Research
2015
Ovarian Tissue Cryopreservation: Where Are We Now?
Bedoschi G, Oktay K. Ovarian Tissue Cryopreservation: Where Are We Now? 2015, 71-78. DOI: 10.1007/978-3-319-17849-3_6.Peer-Reviewed Original ResearchFertility preservationOvarian stimulationOvarian cortical piecesAdvanced treatment strategiesPre-pubertal childrenOvarian cryopreservationCortical piecesSurvival outcomesOvarian functionCancer careCancer patientsTreatment strategiesEndocrine functionOocyte cryopreservationAccelerated phaseEarly detectionCancer communityPatientsTransplantationFirst descriptionStimulationSufficient time periodChemotherapySuccessful restorationCancer
2013
Simplified cycle management for breast cancer patients undergoing fertility preservation with the Letrozole-FSH stimulation protocol
Bedoschi G, Turan V, Moy F, Oktay K. Simplified cycle management for breast cancer patients undergoing fertility preservation with the Letrozole-FSH stimulation protocol. Fertility And Sterility 2013, 100: s169. DOI: 10.1016/j.fertnstert.2013.07.1468.Peer-Reviewed Original ResearchFrozen embryo transfer pregnancy outcomes in breast cancer patients who were stimulated with Letrozole-FSH for fertility preservation
Bedoschi G, Turan V, Oktay K. Frozen embryo transfer pregnancy outcomes in breast cancer patients who were stimulated with Letrozole-FSH for fertility preservation. Fertility And Sterility 2013, 100: s166. DOI: 10.1016/j.fertnstert.2013.07.1455.Peer-Reviewed Original ResearchFertility preservation in young breast cancer patients: addressing individual patient needs
Rodriguez-Wallberg K, Oktay K. Fertility preservation in young breast cancer patients: addressing individual patient needs. Breast Cancer Management 2013, 2: 135-147. DOI: 10.2217/bmt.12.68.Peer-Reviewed Original ResearchBreast cancer patientsFertility preservationCancer patientsAromatase inhibitorsYoung breast cancer patientsOvarian cortical tissueNumber of oocytesStandard stimulation protocolIndividual patient needsReports of childrenFemale patientsEstradiol levelsMenstrual cycleOocyte freezingBreast cancerPsychosocial distressStimulation protocolNormal rangePatient needsPatientsCortical tissueYoung womenImmature oocytesTamoxifenInfertilityFertility preservation in the female with cancer
Rodriguez-Wallberg K, Oktay K. Fertility preservation in the female with cancer. 2013, 273-281. DOI: 10.1017/cbo9780511997761.031.Peer-Reviewed Original ResearchFertility preservationMale cancer patientsFertility preservation strategiesImpact of cancerPost-treatment managementHormone therapySuch patientsCancer patientsNursing staffArtificial reproductive technologiesReproductive endocrinologyTesticular tissueReproductive medicineCancerReproductive technologiesPatientsMale fertilityCliniciansMenCryopreservation of spermChemotherapyPreservation strategiesSurgeryOncologistsTherapy
2011
OC14.06: The role of antral follicle counts (AFC) via TVUSG in determining fertility preservation outcomes in cancer patients undergoing ovarian stimulation
Arslan E, Karsy M, Moy F, Oktay K. OC14.06: The role of antral follicle counts (AFC) via TVUSG in determining fertility preservation outcomes in cancer patients undergoing ovarian stimulation. Ultrasound In Obstetrics And Gynecology 2011, 38: 27-27. DOI: 10.1002/uog.9171.Peer-Reviewed Original ResearchThe role of combined anti-mullerian hormone and antral follicle count assessment in predicting cycle outcomes in cancer patients undergoing controlled ovarian stimulation for fertility preservation
Arslan E, Karsy M, Moy F, Oktay K. The role of combined anti-mullerian hormone and antral follicle count assessment in predicting cycle outcomes in cancer patients undergoing controlled ovarian stimulation for fertility preservation. Fertility And Sterility 2011, 96: s201. DOI: 10.1016/j.fertnstert.2011.07.778.Peer-Reviewed Original ResearchSafety of pregnancy after letrozole-FSH stimulation in breast cancer patients: a prospective comparison of frozen embryo transfer to self vs. gestational carriers
Oktay K, Arslan E, Karsy M, Moy F. Safety of pregnancy after letrozole-FSH stimulation in breast cancer patients: a prospective comparison of frozen embryo transfer to self vs. gestational carriers. Fertility And Sterility 2011, 96: s42-s43. DOI: 10.1016/j.fertnstert.2011.07.162.Peer-Reviewed Original Research
2010
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation
Oktay K, Buyuk E, Rodriguez-Wallberg K, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reproductive BioMedicine Online 2010, 20: 634-638. PMID: 20219430, DOI: 10.1016/j.rbmo.2010.01.012.Peer-Reviewed Original ResearchConceptsBreast cancer patientsMature oocyte yieldCancer patientsOvarian stimulationOocyte yieldFertility preservationFertility preservation cyclesMature oocytesCryopreservation cyclesTotal numberSecondary analysisVitro maturationImmature oocytesPatientsIVMEmbryo cryopreservationFertilization rateOocytesStimulationUseful strategyMaturationChemotherapy
2009
Fertility Preservation for Breast Cancer Patients
Oktem O, Oktay K. Fertility Preservation for Breast Cancer Patients. Seminars In Reproductive Medicine 2009, 27: 486-492. PMID: 19806518, DOI: 10.1055/s-0029-1241059.Peer-Reviewed Original ResearchConceptsBreast cancer patientsOvarian stimulation protocolsCancer patientsBreast cancerFertility preservationCancer survivorsStimulation protocolConventional ovarian stimulation protocolsRise of estrogenOvarian tissue freezingBreast cancer survivorsPreservation of fertilityEndogenous estrogen levelsFertility preservation strategiesAromatase inhibitor letrozolePremature ovarian failureNew cancer casesAdjuvant chemotherapyOvarian stimulationFertilization cyclesEstrogen levelsOvarian failureOocyte freezingReproductive ageCommon neoplasm
2008
Fertility preservation is an emerging discipline extending beyond cancer patients: analysis of a large experience
Oktay K, Sahin G, Ucar K, Barad D, Blanchette H, Gleicher N. Fertility preservation is an emerging discipline extending beyond cancer patients: analysis of a large experience. Fertility And Sterility 2008, 90: s51. DOI: 10.1016/j.fertnstert.2008.07.719.Peer-Reviewed Original Research
2007
Safety of ovarian stimulation with letrozole and gonadotropins in breast cancer patients undergoing embryo or oocyte cryopreservation: a prospective controlled study
Azim A, Oktay K. Safety of ovarian stimulation with letrozole and gonadotropins in breast cancer patients undergoing embryo or oocyte cryopreservation: a prospective controlled study. Fertility And Sterility 2007, 88: s33. DOI: 10.1016/j.fertnstert.2007.07.121.Peer-Reviewed Original Research
2006
O-287 Ovarian reserve is impaired in cancer patients with normal baseline FSH who previously received chemotherapy as determined by response to controlled ovarian stimulation and anti-mullerian hormone measurements: A controlled study
Azim A, Rauch E, Ravich M, Witkin S, Oktay K. O-287 Ovarian reserve is impaired in cancer patients with normal baseline FSH who previously received chemotherapy as determined by response to controlled ovarian stimulation and anti-mullerian hormone measurements: A controlled study. Fertility And Sterility 2006, 86: s123-s124. DOI: 10.1016/j.fertnstert.2006.07.327.Peer-Reviewed Original Research